Professor Ton Schumacher

Professor Ton N. Schumacher is a cancer immunologist known for his work that has established the important role of cancer neoantigens in the body’s natural response against cancer and in the clinical activity of cancer immunotherapies. In addition, his research group has created a number of widely used technologies to dissect T cell responses in cancer and other diseases. Through his work, he has also contributed to the development of adoptive T cell therapies and neoadjuvant cancer immunotherapy.  

Ton is senior member at The Netherlands Cancer Institute, Professor of Immunotechnology at Leiden University, and Oncode Member. He is also, amongst others, elected fellow of the American Association of Cancer Research and the Royal Netherlands Academy of Arts and Sciences, and recipient of the Louis-Jeantet Prize for Medicine, AACR-CRI Lloyd J. Old Award, Meyenburg Cancer Research Award, and W.B. Coley Award.